Immunoglobulin for Necrotizing Soft Tissue Infections: a Randomised Controlled Trial

Trial Profile

Immunoglobulin for Necrotizing Soft Tissue Infections: a Randomised Controlled Trial

Completed
Phase of Trial: Phase II

Latest Information Update: 04 Oct 2016

At a glance

  • Drugs Immune globulin (Primary)
  • Indications Necrosis; Soft tissue infections
  • Focus Therapeutic Use
  • Acronyms INSTINCT
  • Most Recent Events

    • 29 Sep 2016 Status changed from active, no longer recruiting to completed.
    • 02 Mar 2016 Planned End Date changed from 1 Oct 2016 to 1 Sep 2016 as reported by ClinicalTrials.gov.
    • 02 Mar 2016 Planned primary completion date changed from 1 Oct 2016 to 1 Sep 2016 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top